Results 311 to 320 of about 4,829,888 (359)
Some of the next articles are maybe not open access.
2022
How the FDA was shaped by public health crises and patient advocacy, told against a background of the contentious hearings on the breast cancer drug Avastin. Food and Drug Administration approval for COVID-19 vaccines and the controversial Alzheimer's drug Aduhelm made headlines, but few of us know much about how the agency does its work.
openaire +1 more source
How the FDA was shaped by public health crises and patient advocacy, told against a background of the contentious hearings on the breast cancer drug Avastin. Food and Drug Administration approval for COVID-19 vaccines and the controversial Alzheimer's drug Aduhelm made headlines, but few of us know much about how the agency does its work.
openaire +1 more source
Journal of Medicinal Chemistry
This Perspective is a continuation of our analysis of U.S. FDA-approved small-molecule drugs (1938-2012) containing nitrogen heterocycles. In this study we report drug structure and property analyses of 321 unique new small-molecule drugs approved from ...
Christopher M Marshall +4 more
semanticscholar +1 more source
This Perspective is a continuation of our analysis of U.S. FDA-approved small-molecule drugs (1938-2012) containing nitrogen heterocycles. In this study we report drug structure and property analyses of 321 unique new small-molecule drugs approved from ...
Christopher M Marshall +4 more
semanticscholar +1 more source
Nature Reviews Drug Discovery, 2014
Although the FDA's 27 new approvals are down from the 15-year high of 2012, the newcomers pack powerful commercial potential.
openaire +1 more source
Although the FDA's 27 new approvals are down from the 15-year high of 2012, the newcomers pack powerful commercial potential.
openaire +1 more source
FDA Perspective on the Regulation of Artificial Intelligence in Health Care and Biomedicine.
Journal of the American Medical Association (JAMA)Importance Advances in artificial intelligence (AI) must be matched by efforts to better understand and evaluate how AI performs across health care and biomedicine as well as develop appropriate regulatory frameworks.
Haider J. Warraich +2 more
semanticscholar +1 more source